This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.
Onco-Innovations (CBOE CA: ONCO)(OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) announced that it has entered into a termination agreement with Sorbie Bornholm LP and Sorbie Investments LLP to end a performance-based funding arrangement originally announced July 29, 2026. Under the agreement, Sorbie will return an aggregate of 5,380,683 common shares for cancellation, comprising 2,761,635 shares held by Sorbie Bornholm and 2,619,048 shares held by Sorbie Investments. Sorbie Bornholm will receive the remaining credit support corresponding to C$4,444,444, while Onco-Innovations will relinquish its rights to further payments under the arrangement. The transaction will not require an additional cash payment by the company.
Sorbie Investments will also waive its right to receive 2.25 million additional common share purchase warrants, eliminating the company’s obligation to issue those warrants. The termination remains subject to customary closing conditions, including approval from Cboe Canada, and will take effect on a closing date agreed upon by the parties.
To view the full press release, visit https://ibn.fm/nx0ZV
About Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco’s mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. The company holds an exclusive worldwide licence to patented technology directed to the therapeutic inhibition of PNKP, a novel clinical target in DNA damage response.
NOTE TO INVESTORS: The latest news and updates relating to ONNVF are available in the company’s newsroom at https://ibn.fm/ONNVF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
